Treatment Guidelines Materials

This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine. 

This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB. 

This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.

This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB.

This webpage discusses the critical role of early testing, diagnosis, and treatment in controlling the spread of tuberculosis (TB) and saving lives. It highlights local efforts to improve TB prevention and care, focusing on the impact of timely intervention on reducing TB transmission in specific communities. 

This booklet provides comprehensive information on hepatitis C, detailing its impact on liver health, modes of transmission, symptoms, and the importance of testing and treatment. The booklet outlines the progression from acute to chronic infection, potential liver complications, and available diagnostic tests. 

This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.

This journal evaluates the Oregon HOPE TeleHCV study, a peer-facilitated telemedicine model (Peer TeleHCV) for hepatitis C virus (HCV) treatment among people who use drugs (PWUD) in rural Oregon. The findings highlight high patient satisfaction and key factors that enhanced implementation, demonstrating the model’s potential to reduce barriers and improve treatment access.

This webpage explores the risks of untreated hepatitis C, highlighting its potential to cause severe liver damage, cirrhosis, liver failure, and even liver cancer. Beyond liver-related issues, the virus can also contribute to complications such as fatigue, joint pain, kidney disease, and diabetes. Early diagnosis and treatment are essential to preventing these long-term health risks and improving overall well-being.

This guideline outlines the Doxy-PEP Protocol for the prevention of certain sexually transmitted infections (STIs), specifically targeting syphilis, gonorrhea, and chlamydia, following potential exposure. It provides guidelines for healthcare providers on how to administer doxycycline as post-exposure prophylaxis (PEP), detailing protocols for prescription, timing, and patient education to reduce the risk of infection.